466P Efficacy of BRAF inhibitor FORE8394 in BRAF V600+ patients

Autor:	Sherman, E.J. 1, Tsai, F. 2, Janku, F. 3, Allen, C. 4, Yaeger, R. 5, Ammakkanavar, N. 6, Butowski, N. 7, Michelson, G. 8, Paz, M. 9, Tussay-Lindenberg, A. 10, Wang, K. 11, Shepherd, S. 12, Dehan, E. 13, de la Fuente, M. 14, Rodon, J. 15
Zdroj:	In Annals of Oncology September 2022 33 Supplement 7:S754-S754
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu